Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
International Journal of Clinical Oncology|October 15, 2025
Real-world adherence to antiemetic guidelines in Japanese patients receiving high or carboplatin-based moderate emetic risk chemotherapyAyako Okuyama, Takahiro Higashi, Masakazu Abe, et al.Anticancer Research|April 5, 2017
Efficacy of Single-dose First-generation 5-HT3 Receptor Antagonist and Dexamethasone for Preventing Nausea and Vomiting Induced by Low-dose Carboplatin-based ChemotherapyDaizo Kaito, Hirotoshi Iihara, Norihiko Funaguchi, et al.Journal of Pharmaceutical Health Care and Sciences|August 2, 2021
Anorexia, pain and peripheral neuropathy are associated with a decrease in quality of life in patients with advanced pancreatic cancer receiving outpatient chemotherapy - a retrospective observational studyHironori Fujii, Maaya Koda, Shiori Sadaka, et al.BMC Cancer|November 8, 2023
Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time biasDaichi Watanabe, Hironori Fujii, Koichi Ohata, et al.International Journal of Colorectal Disease|July 27, 2025
Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic scoreHironori Fujii, Misato Kani, Daichi Watanabe, et al.Cancer Chemotherapy and Pharmacology|September 5, 2019
Optimal dose of sunitinib for long-term treatment in Japanese patients with renal cell carcinomaYuto Yamada, Yuta Ohno, Yu Kato, et al.Future Oncology (London, England)|March 19, 2025
Nausea and vomiting in an evolving anticancer treatment landscape: long-delayed and emetogenic antibody-drug conjugatesYeon Hee Park, Giampaolo Bianchini, Javier Cortés, et al.Journal of Pharmaceutical Health Care and Sciences|July 10, 2024
CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapyHironori Fujii, Akitaka Makiyama, Kayoko Nishimura, et al.Gynecologic Oncology|January 14, 2020
Efficacy and safety of 5 mg olanzapine combined with aprepitant, granisetron and dexamethasone to prevent carboplatin-induced nausea and vomiting in patients with gynecologic cancer: A multi-institution phase II studyHirotoshi Iihara, Mototsugu Shimokawa, Yoh Hayasaki, et al.International Journal of Clinical Oncology|October 6, 2025
Chemotherapy-related hand-foot syndrome and hand-foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study teamYohei Iimura, Hirotoshi Iihara, Yoshitaka Saito, et al.Pageof 12